Healthcare provider profile · identity verified

Daniel S Raskind, MD

General Practice · BELLEVUE, WA · NPI 1518034834

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	66
Eliquis	Apixaban	223	31
Lisinopril	Lisinopril	212	33
Furosemide	Furosemide	188	38
Metoprolol Succinate	Metoprolol Succinate	181	32
Gabapentin	Gabapentin	177	34
Levothyroxine Sodium	Levothyroxine Sodium	177	40
Tamsulosin Hcl	Tamsulosin Hcl	163	24
Amlodipine Besylate	Amlodipine Besylate	155	30
Baclofen	Baclofen	155	17
Losartan Potassium	Losartan Potassium	137	23
Potassium Chloride	Potassium Chloride	134	20
Pantoprazole Sodium	Pantoprazole Sodium	126	19
Clopidogrel	Clopidogrel Bisulfate	119	16
Duloxetine Hcl	Duloxetine Hcl	118	17
Pregabalin	Pregabalin	114	suppressed
Fentanyl	Fentanyl	112	suppressed
Xarelto	Rivaroxaban	111	suppressed
Trazodone Hcl	Trazodone Hcl	109	19
Metoprolol Tartrate	Metoprolol Tartrate	104	19
Sertraline Hcl	Sertraline Hcl	104	16
Escitalopram Oxalate	Escitalopram Oxalate	95	suppressed
Mirtazapine	Mirtazapine	95	17
Oxycodone Hcl	Oxycodone Hcl	92	24
Carvedilol	Carvedilol	78	12
Spironolactone	Spironolactone	77	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	73	suppressed
Metformin Hcl	Metformin Hcl	73	12
Montelukast Sodium	Montelukast Sodium	68	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	64	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	63	suppressed
Divalproex Sodium	Divalproex Sodium	61	suppressed
Risperidone	Risperidone	60	suppressed
Warfarin Sodium	Warfarin Sodium	58	suppressed
Aripiprazole	Aripiprazole	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	56	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	52	suppressed
Torsemide	Torsemide	51	12
Latanoprost	Latanoprost	50	suppressed
Tramadol Hcl	Tramadol Hcl	50	11
Prednisone	Prednisone	48	suppressed
Atenolol	Atenolol	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	12
Tizanidine Hcl	Tizanidine Hcl	47	suppressed
Finasteride	Finasteride	46	11
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Morphine Sulfate Er	Morphine Sulfate	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	15
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Simvastatin	Simvastatin	38	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	37	suppressed
Metolazone	Metolazone	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Cephalexin	Cephalexin	30	14
Omeprazole	Omeprazole	29	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	28	suppressed
Levofloxacin	Levofloxacin	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	11
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Ozempic	Semaglutide	25	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Morphine Sulfate	Morphine Sulfate	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Sotalol	Sotalol Hcl	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	13
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Famotidine	Famotidine	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Primidone	Primidone	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Erythromycin	Erythromycin Base	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Xifaxan	Rifaximin	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Butrans	Buprenorphine	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Moxifloxacin	Moxifloxacin Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Diazepam	Diazepam	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error